Lucid Diagnostics, a New York-based maker of diagnostic tests for esophageal precancer and cancer, filed for a $58 million IPO, per Axios. The pre-revenue company plans to list on the Nasdaq.
Related Posts
KARE Raises 7.9M for Senior & Post-Acute Care: Report
Golden Section Ventures led the round.
August 17, 2021
Brightspring Registers IPO
Brightspring is a home and community-based healthcare services platform.
October 19, 2021
Petersburg Medical Center (AK) Gets Verbal Confirmation of $20M Grant for New Hospital
The existing hospital is rapidly falling out of code, and repairing it would cost up to $110 million.
October 6, 2023
Monogram Health, Strive Plan Capital Raises for Kidney Care
Monogram closed a $160 million Series B round last year.
October 13, 2022